TriSalus Life Sciences Form 3 MedTech Acquisition / David J. Snyderman ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Magnetar Financial LLC

(Last)

(First)

(Middle)

1603 ORRINGTON AVE.

13TH FLOOR

(Street)

EVANSTON

60201

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/12/2022

3. Issuer Name and Ticker or Trading Symbol
MedTech Acquisition Corp [ MTAC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock	67,992	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾
Class A Common Stock	107,904	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽⁵⁾
Class A Common Stock	391,047	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽⁶⁾
Class A Common Stock	27,894	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽⁷⁾
Class A Common Stock	21,888	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽⁸⁾
Class A Common Stock	68,307	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽⁹⁾
Class A Common Stock	85,137	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽¹⁰⁾
Class A Common Stock	141,570	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽¹¹⁾
Class A Common Stock	131,667	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽¹²⁾
Class A Common Stock	38,080	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽¹³⁾
Class A Common Stock	42,567	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽¹⁴⁾
Class A Common Stock	21,780	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽¹⁵⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

1. Name and Address of Reporting Person^*

Magnetar Financial LLC

(Last)

(First)

(Middle)

1603 ORRINGTON AVE.

13TH FLOOR

(Street)

EVANSTON

60201

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Magnetar Capital Partners LP

(Last)

(First)

(Middle)

1603 ORRINGTON AVE.

13TH FLOOR

(Street)

EVANSTON

60201

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Supernova Management LLC

(Last)

(First)

(Middle)

1603 ORRINGTON AVENUE,

13TH FLOOR

(Street)

EVANSTON

60201

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Snyderman David J.

(Last)

(First)

(Middle)

1603 ORRINGTON AVENUE

13TH FLOOR

(Street)

EVANSTON

60201

(City)

(State)

(Zip)

Explanation of Responses:

1. Magnetar Financial LLC ("Magnetar Financial") serves as investment manager of each of (1) Magnetar Constellation Fund II Ltd, Magnetar Constellation Master Fund, Ltd, Magnetar Healthcare Master Fund Ltd, Magnetar SC Fund Ltd, Magnetar Xing He Master Fund Ltd, and Purpose Alternative Credit Fund Ltd, all of which are Cayman Islands exempted companies, (2) Corbin Hedged Equity Fund, L.P. and Magnetar Structured Credit Fund, LP, all of which are Delaware limited partnerships, (3) Magnetar Lake Credit Fund LLC and Purpose Alternative Credit Fund - T LLC, all of which are Delaware limited liability companies, and (4) LMA SPC (Map 243 Segregated Portfolio) and NR 1 SP, a Segregated Portfolio of North Rock SPC, all of which are Cayman Islands segregated portfolio companies (collectively, the "Magnetar Funds").

2. Magnetar Capital Partners LP ("Magnetar Capital Partners"), a Delaware limited partnership, is the sole member and parent holding company of Magnetar Financial. Supernova Management LLC ("Supernova Management"), a Delaware limited liability company, is the general partner of Magnetar Capital Partners. The manager of Supernova Management is David J. Snyderman, a citizen of the United States of America.

3. Each of the Magnetar Funds, Magnetar Financial, Magnetar Capital Partners, Supernova Management and David J. Snyderman disclaims beneficial ownership of these shares of the Issuer's Common Stock.

4. These securities are held directly by Corbin Hedged Equity Fund, L.P.

5. These securities are held directly by Magnetar Constellation Fund II, Ltd.

6. These securities are held directly by Magnetar Constellation Master Fund, Ltd.

7. These securities are held directly by LMA SPC (Map 243 Segregated Portfolio).

8. These securities are held directly by Magnetar Healthcare Master Fund Ltd.

9. These securities are held directly by Magnetar Lake Credit Fund LLC.

10. These securities are held directly by Magnetar SC Fund Ltd.

11. These securities are held directly by Magnetar Structured Credit Fund, LP.

12. These securities are held directly by Magnetar Xing He Master Fund Ltd.

13. These securities are held directly by NR 1 SP, a Segregated Portfolio of North Rock SPC.

14. These securities are held directly by Purpose Alternative Credit Fund Ltd.

15. These securities are held directly by Purpose Alternative Credit Fund - T LLC.

Remarks:

This Form 3 is being filed solely due to the redemption of 23,046,578 shares of the Issuer's Class A common stock by Issuer stockholders on December 12, 2022, after which the Reporting Persons' aggregate beneficial ownership was above 10%. The Reporting Persons have not acquired and have not sold shares of the Issuer's Class A common stock since being pushed over 10% due to the redemptions on December 12, 2022. Exhibit 99.1 - Joint Filing Agreement Exhibit 99.2 - Limited Power of Attorney

	/s/ Michael Turro, Attorney-in-Fact for David J. Snyderman, as Manager of Supernova Management LLC, which is the General Partner of Magnetar Capital Partners LP, which is in turn the Sole Member of Magnetar Financial LLC	12/22/2022
	/s/ Michael Turro, Attorney-in-Fact for David J. Snyderman, as Manager of Supernova Management LLC, which is the General Partner of Magnetar Capital Partners LP	12/22/2022
	/s/ Michael Turro, Attorney-in-Fact for David J. Snyderman, as Manager of Supernova Management LLC	12/22/2022
	/s/ Michael Turro, Attorney-in-Fact for David J. Snyderman	12/22/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

TriSalus Life Sciences (TLSI) Form 3MedTech Acquisition / David J. Snyderman ownership change